Mannkind (MNKD) Stock: Buy, Sell, or Hold?
MNKD - Mannkind Corporation
$3.75
-0.04 (-1.06%)
▼
5d:
-5.3%
30d:
-2.6%
90d:
+0.0%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When MNKD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: MNKD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: MNKD shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: MNKD is currently trading at $3.75, which is considered oversold relative to its 30-day fair value range of $3.84 to $4.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.4) compared to its historical average (24.9). At these levels, the market is pricing in 5.7% annual earnings growth.
Technical Outlook: Technically, MNKD is showing support break momentum. The price is currently testing key support at $3.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MNKD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.97 (+112.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MNKD is showing support break momentum. The price is currently testing key support at $3.73. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MNKD scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.97 (+112.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.84 -
$4.15
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
60.5%
Protect Your Profits
Holding MNKD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 112.5% below Wall St target ($7.97)
- BULLISH: Expecting earnings turnaround to 5.7% growth with 42.9% revenue growth
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.84 -
$4.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.73
Resistance Level
$4.36
Current Trend
Support Break
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.41
Wall Street Target
$7.97
(+112.5%)
Revenue Growth (YoY)
42.9%
Earnings Growth (YoY)
-34.9%
Profit Margin
-11.1%
Valuation Premium vs History
+5.7% premium
PE vs Historical
29.4 vs 24.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.7%
(market-implied from PE analysis)
1-Year Target
$3.96
(+6%)
2-Year Target
$4.19
(+12%)
3-Year Target
$4.43
(+18%)
3-Yr Target (if PE normalizes)
(PE: 29→25)
PE COMPRESSION
$3.75
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.4, Growth: 325.0%)
$12.66
(+238%)
Base:
(SPY PE: 20.2, Growth: 325.0%)
$8.68
(+132%)
Bear:
(PE: 17.1, Growth: 325.0%)
$7.38
(+97%)
Share & Embed Analysis
Last updated: September 12, 2026 11:29 AM ET
Data refreshes hourly during market hours. Next update: 12:29 PM
Data refreshes hourly during market hours. Next update: 12:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MNKD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 41 HOLD |
Advanced MNKD Option Strategies
Professional options setups generated by AI based on today's MNKD price and gamma walls.
